Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model.

Karsten Ruscher(Lund University), Andreas Meisel(Humboldt-Universität zu Berlin)

PubMed

December 1, 2002

10.1523/jneurosci.22-23-10291.2002

Cited by 452

Related Papers

Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use

|The Lancet Neurology|2009|581

Erythropoietin Is a Paracrine Mediator of Ischemic Tolerance in the Brain: Evidence from an<i>In Vitro</i>Model

|Journal of Neuroscience|2002|387

Blocking Stroke-Induced Immunodeficiency Increases CNS Antigen-Specific Autoreactivity But Does Not Worsen Functional Outcome after Experimental Stroke

|Journal of Neuroscience|2015|76

MicroRNA-124-loaded nanoparticles increase survival and neuronal differentiation of neural stem cells in vitro but do not contribute to stroke outcome in vivo

|PLoS ONE|2018|44

Mental health in myasthenia gravis patients and its impact on caregiver burden

|Scientific Reports|2022|36